Long-term safety and efficacy of vornorexant in Japanese patients with insomnia: A 52-week open-label, randomized trial.

Uchimura N, Kambe D, Hasegawa S, Imadera Y, Yamasaki H, Uchiyama M

Open source

DOI
10.1016/j.sleep.2026.109260
Published
2026 Sep 9
Container
Sleep medicine
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.sleep.2026.109260,
  title = {Long-term safety and efficacy of vornorexant in Japanese patients with insomnia: A 52-week open-label, randomized trial.},
  author = {Uchimura N and Kambe D and Hasegawa S and Imadera Y and Yamasaki H and Uchiyama M},
  year = {2026},
  journal = {Sleep medicine},
  doi = {10.1016/j.sleep.2026.109260},
  url = {https://doi.org/10.1016/j.sleep.2026.109260}
}

RIS

TY  - JOUR
TI  - Long-term safety and efficacy of vornorexant in Japanese patients with insomnia: A 52-week open-label, randomized trial.
AU  - Uchimura N
AU  - Kambe D
AU  - Hasegawa S
AU  - Imadera Y
AU  - Yamasaki H
AU  - Uchiyama M
PY  - 2026
JO  - Sleep medicine
DO  - 10.1016/j.sleep.2026.109260
UR  - https://doi.org/10.1016/j.sleep.2026.109260
ER  - 

APA

N, U., D, K., S, H., Y, I., H, Y., & M, U. (2026). Long-term safety and efficacy of vornorexant in Japanese patients with insomnia: A 52-week open-label, randomized trial.. Sleep medicine. https://doi.org/10.1016/j.sleep.2026.109260

Source records